MedPath

Hypospadias and Exome: Identification of New Genes for Familial Hypospadias

Not Applicable
Completed
Conditions
Hypospadias
Interventions
Genetic: Exome sequencing
Registration Number
NCT02495090
Lead Sponsor
University Hospital, Montpellier
Brief Summary

Hypospadias is the second most common malformation of the male genitalia and consists in a congenital hypoplasia of its ventral face. Hypospadias results from abnormal development of the penis that leaves the urethral meatus proximal to its normal glanular position. Meatus position may be located anywhere along the penile shaft, but more severe forms of hypospadias may have a urethral meatus located at the scrotum or perineum. Glandular and penile anterior represents approximately 70% of all the diagnosed cases.

The frequency of family reached depend on the severity of hypospadias. The number of children which have hypospadias mutation discovered by classical technique is low. Families are often the cause of the discovery of new genes involved in sexual differentiation because they allow comparison of genomes of related persons, and detect more easily mutations.

Detailed Description

The aim of this protocol is to search for new genes involved in genital malformations such as hypospadias. Addressed to families with usual causes of these malformations excluded. The search for these mutations will be done by exome sequencing in families where several cases of hypospadias were identified.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Hypospadiac patients with a familial history of hypospadias
Exclusion Criteria
  • Hypospadiac patients without a family history of hypospadias
  • Hypospadiac patients with a family history of hypospadias where etiology is identified

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
HypospadiasExome sequencingFamilial hypospadias trios (patients + parents)
Primary Outcome Measures
NameTimeMethod
number of new genetic variants1 day

exome sequencing

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hôpital Lapeyronie

🇫🇷

Montpellier Cedex 5, France

© Copyright 2025. All Rights Reserved by MedPath